Rasimcan C. Meral

Internal Medicine
39901 Traditions Dr
Northville, MI 48168

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Unraveling the natural history of lipodystrophy syndromes: insights from the prospective LD-Lync study.

Unraveling the natural history of lipodystrophy syndromes: insights from the prospective LD-Lync study.

Journal: Journal of the Endocrine Society
Published: February 24, 2026

CLINICAL OUTCOMES OF INTRAVENOUS GLUCOCORTICOID THERAPY WITH OR WITHOUT ORBITAL RADIOTHERAPY OR MYCOPHENOLATE MOFETIL IN ACTIVE GRAVES' ORBITOPATHY.

CLINICAL OUTCOMES OF INTRAVENOUS GLUCOCORTICOID THERAPY WITH OR WITHOUT ORBITAL RADIOTHERAPY OR MYCOPHENOLATE MOFETIL IN ACTIVE GRAVES' ORBITOPATHY.

Journal: Acta endocrinologica (Bucharest, Romania : 2005)
Published: April 01, 2025

Tirzepatide for Lipodystrophy.

Tirzepatide for Lipodystrophy.

Journal: medRxiv : the preprint server for health sciences
Published: January 13, 2025

Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response.

Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response.

Journal: Journal of the Endocrine Society
Published: December 25, 2024

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Journal: Diabetes care
Published: November 03, 2024

RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.

RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.

Journal: BMC cancer
Published: July 30, 2024

Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy.

Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy.

Journal: The Journal of clinical endocrinology and metabolism
Published: July 06, 2024

A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial Lipodystrophy.

A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial Lipodystrophy.

Journal: Obesity facts
Published: July 14, 2023

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings.

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings.

Journal: Med (New York, N.Y.)
Published: March 16, 2022

COSMC expression as a predictor of remission in IgA nephropathy.

COSMC expression as a predictor of remission in IgA nephropathy.

Journal: International urology and nephrology
Published: October 20, 2021

Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.

Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.

Journal: The Journal of clinical endocrinology and metabolism
Published: May 21, 2021

Cardiac phenotype in familial partial lipodystrophy.

Cardiac phenotype in familial partial lipodystrophy.

Journal: Clinical endocrinology
Published: October 06, 2020
Showing 1-12 of 26

Last Updated: 09/26/2026